Scottsdale, Arizona, June 14, 2022 – Imaging Endpoints (IE), an imaging CRO (iCRO) that provides comprehensive central imaging services and technology solutions throughout the clinical trial process, announced that the United States Patent and Trademark Office (USPTO) has approved the… Read More
June 2, 2022 - Due to the recent COVID-19-related shutdown of a factory in Shanghai, there is a nationwide shortage of intravenous iodinated contrast media (e.g., iohexol) which is expected to last for several more weeks. As a consequence of… Read More
April 21, 2022 - Imaging Endpoints is regularly looking at different and new designs for clinical trials. Our science expertise, and knowledge of the science behind the imaging, gives us the ability on a multidisciplinary level to develop the best… Read More
April 7, 2022 - The fusion of new therapeutics, imaging, and biomarker development is directing us into an advanced realm of healthcare delivery. Imaging Endpoints understands that every data point counts and is critical for successful trial completion, from Phase… Read More
March 31, 2022 - Imaging Endpoints congratulates Novartis for its recent Food and Drug Administration (FDA) approval of Locametz® and Pluvicto™. The FDA approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with prostate-specific membrane antigen… Read More
March 23, 2022 - Last week Imaging Endpoints had a great opportunity to join the entire stakeholder community at the Immuno-Oncology 360° Conference (“IO360”) as a founding sponsor for the 8th consecutive year. Our CMO, Ron Korn, MD, Ph.D. presented… Read More
March 17, 2022 - Imaging Endpoints is at the IO360 Conference in New York from March 16th – 18th alongside the entire stakeholder community including scientists and experts in clinical trial design, from around the world. We’re proud that on… Read More
March 15, 2022 - Imaging Endpoints is joining colleagues from around the world at the IO360 Conference in New York, March 16th – 18th. We proudly present our Chief Medical Officer, Ronald Korn, MD, Ph.D. deliver remarks on “Using Imaging… Read More
March 11, 2022 - We’d love to connect at the IO360 Conference in New York between March 16th and 18th. Please drop by our booth in the DE Foyer (Booth #27) or visit https://calendly.com and schedule a private meeting. We’re… Read More
March 8, 2022 - Imaging Endpoints will be at Immuno-Oncology 360° (“IO360”) from the 16th through the 18th of March. Imaging Endpoints is proud to be the lead sponsor for the 8th year in a row. IO360 provides a unique… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
